Lilly Looks For Sepsis Biomarkers That Could Aid Xigris Administration
This article was originally published in The Pink Sheet Daily
Executive Summary
Studies are underway to support the use of protein C as a biomarker, Lilly Senior Medical Director for Cardiovascular & Acute Care Macias tells a recent CDER seminar. Data suggest Xigris, a form of activated protein C, has higher survival rates when administered early. Biomarkers could be a signal for use.